Skip to main content
    C

    Cardiff Oncology Inc (CRDF)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.85
    +0.12 (+16.75%)

    Market Cap: $56.49M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Cardiff Oncology Inc (CRDF) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cardiff Oncology are Oncolytics Biotech (ONCY), Champions Oncology (CSBR) and ImageneBio (IMA). By market cap, Cardiff Oncology ranks 6th of the 13 companies on this page; Nkarta (NKTX) is the largest at $85.23M.

    Peer Comparison

    CRDF's revenue growth of -14.1% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cardiff Oncology (CRDF)$56.49MN/A115.5x0.0%N/A-14.1%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Champions Oncology Inc (CSBR)$65.49MN/A1.0x-1.9%N/A8.8%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Nkarta Inc (NKTX)$85.23MN/AN/A0.0%N/A0.0%0.00%
    Gossamer Bio Inc (GOSS)$67.10MN/A0.9x-159.5%147.4%189.1%0.00%
    RenovoRx Inc (RNXT)$50.18MN/A16.6x0.0%N/A300.8%0.00%
    Actinium Pharmaceuticals Inc (ATNM)$51.56M4.1x1.3x32.2%N/A-100.0%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Tiziana Life Sciences Ltd (TLSA)$72.53MN/AN/A0.0%N/A0.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Cognition Therapeutics Inc (CGTX)$64.65MN/AN/A0.0%N/A0.0%0.00%
    Peer median$50.87M4.1x1.3x0.0%67.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cardiff Oncology, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    Champions Oncology Inc (CSBR)
    Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States.
    CSBR competitors
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Nkarta Inc (NKTX)
    Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and markets cell therapies for the treatment of cancer.
    NKTX competitors
    Gossamer Bio Inc (GOSS)
    Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing...
    GOSS competitors
    RenovoRx Inc (RNXT)
    RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors.
    RNXT competitors
    Actinium Pharmaceuticals Inc (ATNM)
    Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation...
    ATNM competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Tiziana Life Sciences Ltd (TLSA)
    Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat...
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Cognition Therapeutics Inc (CGTX)
    Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting...
    CGTX competitors

    Frequently Asked Questions About CRDF

    Who are Cardiff Oncology's main competitors?

    The companies most similar to Cardiff Oncology include Oncolytics Biotech (ONCY), Champions Oncology (CSBR), ImageneBio (IMA), Nkarta (NKTX) and Gossamer Bio (GOSS), listed from the closest match.

    Who is Cardiff Oncology's biggest competitor?

    Nkarta (NKTX) is the largest of the similar companies at $85.23M; Oncolytics Biotech (ONCY) is the closest match by business profile, size, sector and industry.

    How does CRDF stock compare with its competitors?

    CRDF's P/S is 115.5x against a peer median of 1.3x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Cardiff Oncology's competitors pays a higher dividend?

    Cardiff Oncology pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Cardiff Oncology bigger than its competitors?

    No. Cardiff Oncology is 6th by market cap among the 13 companies on this page; the largest is Nkarta (NKTX) at $85.23M.